Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole.

• Главные авторы: Kota Yoshioka (Автор), Jennifer Manne-Goehler (Автор), James H Maguire (Автор), Michael R Reich (Автор)
• Формат: ‌
• Опубликовано: Public Library of Science (PLoS), 2020-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Approximately 300,000 persons in the United States (US) are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease, but less than 1% are estimated to have received antiparasitic treatment. Benznidazole was approved by the US Food and Drug Administration (FDA) for treatment of T. c...